can i switch from tirzepatide to semaglutide and key differences, weight loss results (2026) Can I Switch from Tirzepatide

Research demonstrates that AOD-9604 upregulates beta-3 adrenergic receptors in fat cells, promoting energy expenditure and fat oxidation through mechanisms distinct from traditional stimulants or full growth hormone

In the SURMOUNT-1 trial for tirzepatide (Mounjaro), a hair loss incidence of up to 5% was documented among participants receiving the highest doses

The Pharmacokinetics Behind the Switch Timing The 1 to 2 week washout recommendation is not arbitrary

Most patients benefit from 1-3 weekly sessions over 4-8 weeks

I will tell you, in the phase three trials, anywhere from 8 to 15% of individuals in the trials so we know they're taking the drug do not lose at least 5% of their body weight